BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 11, 2007
View Archived Issues
Summary of studies evaluating the effect of various natural products on diabetes
Read More
Profile of the antithrombotic agent rivaroxaban
Read More
Preclinical studies characterize the antithrombotic effect of MCC-977
Read More
Rapid, high-level platelet inhibition seen with PRT-060128 in humans
Read More
Antithrombotic activity seen with TGX-221 in vivo
Read More
Withaferin A holds promise as a potential drug lead
Read More
Alkaline phosphatase shows promise in ulcerative colitis
Read More
Peregrine acquires rights to antiangiogenesis technology from M.D. Anderson
Read More
ADL-5859 begins phase II pain study
Read More
Enrollment completed in phase II cardiovascular restenosis trial of Resten-MP
Read More
GRN-163L begins phase I/II study in advanced NSCLC
Read More
Biologics Menoflavon launched in Canada
Read More
Recent patents disclose novel antiinfective agents
Read More
DSM and Crucell sign licensing agreement with Masterclone to develop antibody
Read More
NPS and Nycomed expand Preotact agreement
Read More
Update on Karo Bio and Merck collaboration
Read More
CV Therapeutics identifies potential first-in-class MOA for ranolazine
Read More
Gilead initiates expanded access program for aztreonam lysine for CF
Read More
CB-7630 shows activity in prostate cancer trials
Read More
Nimotuzumab shown to bind to EGF receptor and potentiate radiotherapy
Read More
U.S. orphan drug designation for Corlux in Cushing's syndrome
Read More
New agents for gastrointestinal disorders described in recent patents
Read More
Zybrestat begins pivotal study in anaplastic thyroid cancer
Read More
Novel analgesic agents imparted in recent patent literature
Read More
NV-1020 shows promise in metastatic colorectal cancer
Read More
